drugset / Trial / NCT02749968

Intercostal Liposomal Bupivacaine for the Management of Blunt Chest Wall Trauma

NCT02749968 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

This is a study of liposomal bupivacaine for pain control in patients with blunt chest wall trauma.

Timeline

Start
2018-03-09
Primary completion
2021-01-01
Completion
2021-01-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 1 ml Other

Indications

No indication recorded.